1. June 18, 2021

    Assessing the prevalence of Barrett's esophagus in patients with scleroderma

    Study results suggest that women with scleroderma should be included in the screening recommendations for Barrett's esophagus and treated accordingly if dysplasia is found.

  2. June 18, 2021

    Assessing the performance of methylated DNA markers in blood for detection of pancreatic ductal adenocarcinoma

    A blood test combining methylated DNA markers with carbohydrate antigen 19-9 detects pancreatic ductal adenocarcinoma with high accuracy.

  3. June 18, 2021

    Using a phenotype-guided approach for the treatment of obesity

    Actionable phenotypes of obesity based on pathophysiology and behavior can help individualize pharmacotherapy and enhance outcomes.

  4. June 11, 2021

    Where we are with gastric and esophageal cancers

    A Mayo Clinic medical oncologist answers questions about diagnosis and screening and discusses treatment advances in recent years for gastric and esophageal cancers.

  5. June 03, 2021

    Mayo Clinic study provides clarity on use of anticoagulants in gastrointestinal cancers

    ROCHESTER, Minn. -- A study by Mayo Clinic researchers provides some clarity in the use of direct oral anticoagulants (DOAC), such as apixaban and rivaroxaban, to treat acute venous thromboembolism (VTE) in patients w[...]

  6. April 17, 2021

    Encouraging innovation in gastroenterology and endoscopy

    Mayo Clinic gastroenterologist Elizabeth Rajan, M.D., answers questions about the skills and processes that guide physician-investigators working on device and technology innovation.

  7. April 17, 2021

    Young-onset esophageal adenocarcinoma: Results from a population-based study

    Mayo Clinic research examining the incidence, stage distribution and survival outcomes associated with esophageal adenocarcinoma (EAC) in a large population-based study yields some surprising results about young-onset E[...]

  8. April 17, 2021

    Understanding and managing chronic abdominal bloating and distension

    Mayo Clinic gastroenterologists review the epidemiology, effects and pathophysiology of chronic bloating and distension and describe diagnostic strategies and available treatment options.

  9. March 05, 2021

    mt-sDNA test shows high specificity for colorectal cancer screening in average-risk 45- to 49-year-olds

    The multitarget stool DNA (mt-sDNA) test showed more than 95% specificity in a cross-sectional study of 45- to 49-year-old patients at average risk for colorectal cancer.

  10. Feb. 13, 2021

    Convolutional neural network trained to distinguish autoimmune pancreatitis from pancreatic ductal adenocarcinoma and benign pancreas conditions

    Using an extensive endoscopic ultrasound image and video database, researchers developed and validated a convolutional neural network trained to distinguish autoimmune pancreatitis from pancreatic ductal adenocarcinoma [...]

  11. Feb. 13, 2021

    Updates from trials of microbiome restoration products

    Multiple trials are examining alternatives to fecal microbiota transplantation, including capsule- and enema-based therapies, for treatment of recurrent Clostridioides difficile infection.

  12. Feb. 13, 2021

    Esophageal dysfunction after bariatric surgery

    Esophageal dysmotility disorders, including an achalasia-like condition referred to as post-obesity surgery esophageal dysfunction (POSED), may be an underrecognized bariatric surgery complication.

  13. Feb. 13, 2021

    Screening strategies for prevalent esophageal adenocarcinoma may be different from those recommended for Barrett's esophagus

    Researchers find evidence that a second phenotype of esophageal adenocarcinoma is not associated with chronic gastroesophageal reflux and other Barrett's esophagus risk factors.

  14. Feb. 12, 2021

    Body fat investigation provides insights for ‘obesity paradox’

    High levels of unsaturated fat in the diet and in visceral fat composition can worsen outcomes of acute pancreatitis in lean individuals — an example of the obesity paradox.

  15. Feb. 05, 2021

    Understanding post-infection irritable bowel syndrome: A large population-based study

    Using Minnesota Department of Health surveillance data, researchers confirmed that 1 in 5 patients diagnosed with campylobacter infection may develop post-infection irritable bowel syndrome (PI-IBS).

  16. Feb. 05, 2021

    How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D.

    Prospective disease evaluation, improved control of confounding factors, and obesity measures that reflect visceral adipose tissue are needed to understand obesity's role in the pathogenesis and management of inflammato[...]

  17. Feb. 05, 2021

    The use of transoral outlet reduction endoscopy to manage weight regain after gastric bypass: A comparison of 2 endoscopic techniques

    Meta-analysis supports that full-thickness suturing plus argon plasma mucosal coagulation and argon plasma mucosal coagulation both offer safe, sustained weight-loss outcomes for patients who regain weight following Rou[...]

  18. Feb. 05, 2021

    Management of recurrent Clostridioides difficile infection and use of fecal microbiota transplantation during the COVID-19 pandemic

    Testing and COVID-19 status matching of both stool donors and fecal microbiota transplantation (FMT) recipients must occur to prevent transmitting COVID-19 via FMT using donor stool.

  19. Jan. 19, 2021

    Mayo Clinic's Pediatric Liver Clinic provides exceptional care for patients requiring transplant

    Mayo Clinic Pediatric Liver Clinic specialists deliver an extensive evaluation to provide a comprehensive assessment and treatment plan for pediatric patients with liver disease.

  20. Nov. 02, 2020

    Mayo Clinic study finds 1 in 8 patients with cancer harbor inherited genetic mutations

    The Interrogating Cancer Etiology Using Proactive Genetic Testing (INTERCEPT) study represents the largest known multicenter study of universal testing of patients with cancer.

  21. Aug. 28, 2020

    Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies

    Daniel H. Ahn, D.O., talks about the latest advancements and research in colorectal cancer treatment.

  22. Aug. 15, 2020

    Avoiding a drainage tube through the skin for patients with postoperative abdominal fluid collections

    The study results suggest endoscopic ultrasound-guided drainage of postoperative fluid collections is a safe, effective alternative to percutaneous drain placement.

  23. Aug. 15, 2020

    Examining COVID-19 polymerase chain reaction testing before endoscopy

    A Mayo Clinic study used computer modeling to compare different approaches for COVID-19 testing in patients requiring semi-urgent and elective endoscopies.

  24. Aug. 15, 2020

    Studying bowel prep for capsule endoscopy

    A Mayo Clinic study investigates the use of comprehensive purgative preparation combined with right lateral positioning.

  25. Aug. 15, 2020

    Comparing modalities for detecting dysplasia in patients with IBD

    A one-year cross-sectional IBD surveillance colonoscopy cohort compares high-definition white light endoscopy and chromoendoscopy.

  26. June 16, 2020

    Mayo Clinic, NASA team up to test AI algorithm on colorectal cancer

    A Center for Individualized Medicine algorithm shows potential in detecting spatio-temporal patterns of colorectal cancer progression from tumor snapshots to predict the cancer's evolutionary trajectory.

  27. May 13, 2020

    Esophageal cancer treatment amid COVID-19: Q&A with Shanda Blackmon, M.D., M.P.H.

    Thoracic surgeon Dr. Blackmon provides her perspective on how COVID-19 has affected esophageal cancer treatment and what patients should know about receiving care during this pandemic.

  28. April 18, 2020

    Understanding the role of proteolytic activity in mediating irritable bowel syndrome symptoms and disruption of intestinal barrier function

    Mayo Clinic researchers examined fecal proteolytic activity in individuals with post-infection and constipation-predominant irritable bowel syndrome, and its association with clinical symptoms and microbiota composition[...]

  29. April 18, 2020

    Diagnosis and management of patients with chronic constipation

    Adil E. Bharucha, M.B.B.S, M.D., answers key questions about the diagnosis and management of patients with this common condition.

  30. April 18, 2020

    Understanding the clinical significance of disease detected by imaging but not by ileoscopy or biopsy

    Researchers conclude that patients with evidence of ileal inflammation on enterography are likely to have active inflammatory disease, even when results of ileoscopy and biopsy appear normal.

  31. April 18, 2020

    Examining the role of visceral fat in worsening inflammation, organ failure and reduced survival in patients with acute pancreatitis

    A Mayo Clinic study describes the progression of visceral adipose injury, rapid fat necrosis, worsening inflammation and organ failure that can occur during acute pancreatitis.

  32. March 02, 2020

    Immune cells may improve accuracy of predicting survival in colorectal cancer

    ROCHESTER, Minn. -- The density of immune cells, called tumor infiltrating lymphocytes, when combined with analysis of tumor budding may serve as a method to more accurately predict survival in patients with stag[...]

  33. Feb. 14, 2020

    Prepless colon capsule technology: New research examines this less invasive approach to colorectal cancer screening

    Mayo gastroenterologists are collaborating in the first U.S. study evaluating the safety and compliance of a prepless capsule imaging system for colorectal cancer (CRC) screening.

  34. Feb. 14, 2020

    Role of AI in detection and management of colorectal polyps and cancer

    Up to 25% of polyps can be missed during colonoscopy, due to factors such as withdrawal time, preparation quality and the endoscopist's ability to recognize flat polyps.

  35. Feb. 14, 2020

    Reducing post-polypectomy bleeding events in patients who require antithrombotic agents

    Mayo Clinic gastroenterologist Neena S. Abraham, M.D., M.S., reviews research findings related to the use of antithrombotic agents, polypectomy techniques and prophylactic placement of hemostatic clips, and their impact[...]

  36. Feb. 14, 2020

    Detection of esophageal cancer via assay of novel methylated DNA markers in plasma

    In the largest plasma-based pilot of esophageal cancer biomarkers to date, Mayo Clinic researchers identified five methylated DNA markers (MDMs) that achieved high discrimination for cancer.

  37. Feb. 14, 2020

    Update on hereditary gastrointestinal cancers: Lynch syndrome and familial adenomatous polyposis syndromes

    A primer on Lynch syndrome, familial adenomatous polyposis (FAP) and attenuated FAP provides clinicians with tools to understand the genetic bases of these conditions and appropriate diagnosis and management.

  38. Feb. 14, 2020

    Novel approaches to the diagnosis of bile acid diarrhea

    In this Q and A, Mayo Clinic gastroenterologist Michael Camilleri, M.D., discusses the available and developing approaches to the diagnosis of bile acid diarrhea.

  39. Feb. 14, 2020

    Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis

    A head-to-head comparison suggests that vedolizumab is slightly superior to adalimumab for moderately to severely active ulcerative colitis and should be considered a first line biologic for this disease.

  40. Oct. 22, 2019

    Panel of methylated DNA markers provides improved accuracy in detecting advanced neoplasia and other lesions that may require resection

    Researchers identified and validated a panel of DNA methylation markers that can detect advanced neoplasia and help determine which cysts require surgery.

  41. Oct. 22, 2019

    The emerging role of AI in medicine, gastroenterology and hepatology

    In this Q & A, Mayo Clinic gastroenterologist Shounak Majumder, M.D., discusses this tool's potential impact within health care and within ongoing research, clinical practice and education efforts.

  42. Oct. 22, 2019

    Assessing the timeline, location and patterns of recurrence in patients achieving complete remission after radiofrequency ablation

    Researchers assessed the timeline, location and patterns of recurrence in patients who achieved remission after radiofrequency ablation in a multicenter cohort study.

  43. Oct. 22, 2019

    Evaluating the safety and diagnostic accuracy of endoscopic fine-needle aspiration for detection of extravascular migratory metastases in the pancreas

    In a retrospective review, researchers demonstrated that cytology analysis of pancreatic samples collected by endoscopic ultrasound fine-needle aspiration (EUS-FNA) can detect extravascular migratory metastases often mi[...]

  44. Aug. 16, 2019

    Use of interventional endoscopy in management of gastrointestinal disorders and post-surgical complications in high-risk patients

    New endoscopic strategies can obviate the need for invasive surgeries, as well as mitigate the complications of gastrointestinal surgeries in high-risk patients.

  45. Aug. 16, 2019

    Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    Researchers developed and validated a model that predicts the influence of clinical and genetic factors on an individual's responsiveness to anti-TNF therapy.

  46. Aug. 16, 2019

    EMR Scar Assessment Project for Endoscope (ESCAPE) trial helps determine when biopsy is necessary

    Researchers seek to determine which tools can help clinicians maximize the accuracy of optical diagnosis and avoid unnecessary biopsy.

  47. Aug. 16, 2019

    Research establishes strong association between family history and increased risk of colorectal cancer in patients with inflammatory bowel diseases

    A large study demonstrates an elevated risk of colorectal cancer in individuals with inflammatory bowel disease (IBD) and in individuals with IBD who have a close relative with colorectal cancer.

  48. June 11, 2019

    Update on IBS treatments: Examining the efficacy of antidepressants, psychological therapies, prebiotics, probiotics, synbiotics and antibiotics

    Researchers share new information about efficacy of antidepressants, psychological therapies, prebiotics, probiotics, synbiotics and antibiotics in treating individuals with irritable bowel syndrome (IBS).

  49. June 11, 2019

    The microbiome, fecal microbiota transplants and inflammatory bowel disease

    Understanding dysbiosis — the disruption in the bacterial communities that populate the intestinal tract — may lead to a new role for fecal microbiota transplants in treating inflammatory bowel disease.

  50. June 11, 2019

    3 factors associated with improved outcomes for individuals with pancreatic ductal adenocarcinoma

    A Mayo Clinic study finds that a pre-surgery treatment plan focused on three factors can extend life years beyond the average survival time.

  51. April 13, 2019

    Positive patient outcomes associated with liver transplant plus sleeve gastrectomy combination

    Study participants undergoing simultaneous liver transplant and sleeve gastrectomy had a more effective and more durable weight loss, as well as fewer metabolic complications.

  52. April 13, 2019

    New vein of research focuses on inducing pancreatic hypothermia to reduce injury associated with mild and severe acute pancreatitis

    In an article published in Gastroenterology, researchers share findings that they hope will improve the understanding of how best to manage this condition in humans.

  53. April 13, 2019

    Use of endoscopic submucosal dissection for treatment of gastrointestinal lesions

    Although its adoption in Western countries has been slow, experienced endoscopists are now using endoscopic submucosal dissection (ESD) to treat premalignant and early-stage malignant lesions within the stomach, esophag[...]

  54. Feb. 16, 2019

    Examining the role of gut microbial composition and function in weight loss

    Mayo Clinic researchers compared clinical characteristics and gut microbial composition and function in 26 adult study participants.

  55. Feb. 16, 2019

    Transoral endoscopic incisionless fundoplication

    Barham K. Abu Dayyeh, M.D., M.P.H., answers key questions about transoral incisionless fundoplication and provides an overview of recent research findings evaluating the efficacy of this approach.

  56. Feb. 16, 2019

    A closer look at sarcopenia and the role of exercise in liver transplant candidates

    Results from two multicenter studies help address the problem of progressive loss muscle mass and associated outcomes in liver transplant patients.

  57. Feb. 09, 2019

    Advanced imaging and endoscopic tools enhance diagnosis and treatment of PSC and cancer surveillance

    Mayo specialists employ highly specialized magnetic resonance cholangiopancreatography (MRCP) to diagnose and manage primary sclerosing cholangitis (PSC) in a large cohort of patients.

  58. Feb. 09, 2019

    Nonpharmacological approaches to management of functional gastrointestinal disorders — Where are we now?

    Gastroenterologists discuss the Mayo Clinic experience and research in the use of dietary interventions and other nonpharmacological measures to manage irritable bowel syndrome and other functional gastrointestinal diso[...]

  59. Feb. 09, 2019

    Advances in the treatment of Crohn's disease and ulcerative colitis

    When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

  60. Oct. 23, 2018

    Evaluating the role of peroral endoscopic myotomy in the treatment of achalasia

    Available study data suggest that in the hands of a well-trained endoscopist, peroral endoscopic myotomy (POEM) can combine the performance of surgical myotomy with the safety profile of an endoscopic procedure.

  61. Oct. 23, 2018

    Esophageal cancers: Recent advances and challenges associated with early detection

    Because early diagnosis is associated with improved survival rates for both esophageal adenocarcinoma and squamous cell carcinoma, the search for accurate, cost-effective and widely accepted screening tools remains a pr[...]

  62. Oct. 23, 2018

    Updated IDSA guideline for treatment of Clostridium difficile infection

    Mayo Clinic gastroenterologists discuss new Clostridium difficile infection (CDI) treatment recommendations developed by the Infectious Diseases Society of America and Society for Healthcare Epidemiology of America, add[...]

  63. Oct. 18, 2018

    Endoscopic mucosal resection for management of large colorectal polyps

  64. Aug. 18, 2018

    ACS announces new guideline for colorectal cancer screening for adults at average risk

    In an announcement published in late May, the American Cancer Society released a new guideline recommending that regular screening for colorectal cancer should begin at age 45 for adults at average risk.

  65. Aug. 18, 2018

    Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis

    Tofacitinib, a Janus kinase (JAK) inhibitor, is the first oral medication approved for chronic use in this indication.

  66. Aug. 18, 2018

    Pancreatic cancer screening in high-risk individuals

    Because pancreatic cancer and precursor lesions detected early are potentially curable with surgery, there is growing interest in evaluating whether screening of high-risk individuals is effective.

  67. June 13, 2018

    Transoral outlet reduction with full thickness endoscopic suturing addresses weight regain after gastric bypass

    Transoral outlet reduction endoscopy (TORe) is a novel approach to reducing the stoma diameter that can be performed on an outpatient basis.

  68. June 12, 2018

    Inflammatory bowel disease biobank research update

    Researchers from Mayo Clinic's inflammatory bowel disease (IBD) biobank are hopeful that serologic and genetic markers will help them develop therapeutic approaches tailored to an individual's unique genetic or molecula[...]

  69. June 12, 2018

    Opioid-induced esophageal dysfunction

    Opioid-induced esophageal dysfunction is the subject of multiple studies conducted by Mayo Clinic researchers and colleagues.

  70. April 14, 2018

    Laparoscopic gastrectomy for gastric cancer

    The minimally invasive procedure offers faster recovery, less blood loss and pain, and a return to eating and normal bowel function more quickly. The hospital stay is shorter and the patient is less likely to need a fee[...]

  71. April 13, 2018

    Clip-assisted endoscopic full-thickness resection and biopsy techniques

    Clip-assisted endoscopic full-thickness resection (EFTR) and endoscopic full-thickness biopsy (EFTB) provide an alternative to surgery in the management of epithelial and subepithelial lesions and diagnosis of neuromusc[...]

  72. April 13, 2018

    Transforming noninvasive liver disease detection by MRE: the hepatogram

    Mayo researchers recently studied the use of magnetic resonance elastography (MRE) to detect nonalcoholic steatohepatitis (NASH) in its earlier stages, before the onset of fibrosis.

  73. April 13, 2018

    Assessing the risk of tumoremia after endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma

    Although endoscopic ultrasound-guided fine-needle aspiration is thought to be safe, some experts question whether tumor manipulation during this procedure causes tumors to shed cells into the bloodstream.

  74. Feb. 27, 2018

    Role of novel DNA methylation markers in detection of advanced neoplasia in pancreatic cysts

    Researchers successfully identified and validated novel methylated DNA markers in pancreatic tissue that discriminate — more accurately than currently available cyst fluid markers — high-grade precursor lesi[...]

  75. Feb. 27, 2018

    Diagnosis and management of small bowel bleeding: Update on diagnostic and therapeutic tools

    Important issues to consider in the diagnosis and management of small bowel bleeding include appropriate selection of patients for evaluation, optimal selection and timing of tests, and an understanding of when a conser[...]

  76. Feb. 27, 2018

    Inherited cancers clinic seeks to advance understanding, diagnosis and management of hereditary colorectal cancers

    Use of a simple questionnaire of personal and family history of cancer in outpatient settings helps improve the identification of high-risk patients and families, detect cancers earlier, and formulate more-effective ind[...]

  77. Feb. 20, 2018

    NAFLD and NASH research update

    Mayo Clinic researchers are exploring several new treatment options for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

  78. Feb. 20, 2018

    Understanding HCV and evolving treatment guidelines

    Hugo E. Vargas, M.D., a gastroenterologist and hepatologist specializing in viral hepatitis and liver transplantation at Mayo Clinic's campus in Arizona, answers several key questions about hepatitis C virus (HCV) infec[...]

  79. Feb. 20, 2018

    Identifying diarrhea caused by bile acid malabsorption

    Bile acid malabsorption occurs in about one-third of patients diagnosed with irritable bowel syndrome with diarrhea. The serum 7αC4 test and the fecal bile acid excretion test help identify these patients so that [...]

  80. Feb. 20, 2018

    Targeted DNA next-generation sequencing aids the molecular assessment of pancreatic neuroendocrine tumors

    A recent Mayo Clinic study demonstrated that endoscopic ultrasound-acquired cytology-based tumor genotyping can reveal a spectrum of genetic variants, which may help guide biomarker-driven, individualized, targeted trea[...]

  81. Nov. 17, 2017

    Use of dietary strategies in treating eosinophilic esophagitis

    Mayo Clinic gastroenterologist Jeffrey A. Alexander, M.D., explains current research findings and clinical experience related to the use of elimination diets in the treatment of eosinophilic esophagitis.

  82. Nov. 17, 2017

    Current and emerging pharmacological treatment options for irritable bowel syndrome

    A growing number of available and emerging pharmacological options for the treatment of irritable bowel syndrome (IBS) seek to alter the disease-modifying mechanisms leading to gut dysfunction or the long-term natural h[...]

  83. Nov. 17, 2017

    Mucosal healing in inflammatory bowel disease

    Many experts believe that incorporating endoscopy and other objective markers of mucosal healing into treatment algorithms for patients with inflammatory bowel disease (IBD) will help maximize quality of life and reduce[...]

  84. Sept. 16, 2017

    Current and emerging therapies for PBC

    Researchers exploring new treatments for primary biliary cholangitis (PBC) are hopeful that the 2016 FDA approval of obeticholic acid and novel therapeutic agents currently under investigation will yield new options for[...]

  85. Sept. 16, 2017

    Placement of mesenchymal stem cell-coated matrix induces clinical healing and radiographic response in fistulas

    Results of a small study recently published by Mayo Clinic researchers show that using a synthetic, biodegradable matrix impregnated with stem cells may be an effective treatment for fistulizing perianal Crohn's disease[...]

  86. July 17, 2017

    Comparing the risk of gastrointestinal bleeding associated with direct oral anticoagulants

    This retrospective, propensity-matched study provides head-to-head comparisons of dabigatran, rivaroxaban and apixaban to help evaluate their risk of causing gastrointestinal (GI) bleeding.

  87. July 15, 2017

    Evaluating the efficacy of ESG as a minimally invasive nonsurgical endoscopic intervention for obesity

    Study results published in Clinical Gastroenterology and Hepatology and Obesity Surgery evaluate the procedure's durability and effects on body weight and gastrointestinal function.

  88. July 15, 2017

    Surveillance of colorectal dysplasia and cancer in inflammatory bowel disease

    David H. Bruining, M.D., a gastroenterologist specializing in inflammatory bowel disease (IBD) and endoscopic imaging at Mayo Clinic's campus in Rochester, Minnesota, answers several key questions about colorectal cance[...]

  89. July 14, 2017

    Technical advances have improved safety, efficacy of endoscopic submucosal dissection

    Endoscopic submucosal dissection (ESD) allows en bloc resection of pre-malignant and early-stage malignant lesions of the stomach, colorectum and esophagus with curative rates comparable to surgery. The technique is cha[...]

  90. July 14, 2017

    Mayo Clinic streamlines hepatocellular carcinoma treatment

    Mayo Clinic's efficient, coordinated care leads to superior outcomes in liver cancer and liver transplantation.

  91. May 19, 2017

    Management of post-surgical complications involving the GI tract

    Careful assessment and avoiding an urge to use one approach for all or a "shotgun approach" are critical when planning the management of gastrointestinal defects and leaks.

  92. May 19, 2017

    Association between gastric acid suppression and risk of primary C. diff infection

    In a meta-analysis of 16 studies involving 7,703 patients, Mayo researchers found evidence linking recurrent Clostridium difficile infections (CDIs) with use of these medications.

  93. May 19, 2017

    Frequently asked questions about complex polypectomies

    Polyp size, location and morphology determine the complexity of endoscopic excision and its risk of complications. In this article, Mayo Clinic gastroenterologists provide some answers to frequently asked questions abou[...]

  94. March 28, 2017

    Treatment of Zenker's diverticulum

    Mayo Clinic experience and recently published data suggest that one or two treatments using a flexible endoscopic approach can provide a high rate of symptom relief and a low rate of diverticular recurrence or persisten[...]

  95. March 28, 2017

    Biosimilars for IBD: What you need to know now

    Edward V. Loftus Jr., M.D., a gastroenterologist specializing in inflammatory bowel disease (IBD) at Mayo Clinic's campus in Rochester, Minnesota, addresses several key questions about biosimilars and their potential ro[...]

  96. March 28, 2017

    The role of lifestyle-related treatments for IBS

    Therapeutic options for irritable bowel syndrome (IBS) focus on alleviating symptoms. This article addresses the role of diet, exercise and sleep modifications in the treatment of IBS.

  97. Jan. 14, 2017

    Endoscopic fundoplication bridges gap in GERD management

    Many patients with gastroesophageal reflux disease (GERD) have a suboptimal response to proton pump inhibitors (PPIs). Long-term use is associated with a growing list of adverse events. Endoscopic fundoplication has eme[...]

  98. Jan. 14, 2017

    Two drugs offer new options for IBD

    Ustekinumab was recently approved for patients with Crohn's disease who fail to respond to anti-TNF agents. Oral tofacitinib may be approved for ulcerative colitis by the end of 2017.

  99. Jan. 13, 2017

    Chromoendoscopy better than random biopsies for IBD surveillance, but…

    In many studies, chromoendoscopy has proved superior to random biopsies for dysplasia detection in irritable bowel disease surveillance programs. But the technique remains a supplement to biopsy sampling, mainly due to [...]

  100. Dec. 08, 2016

    Does donor stool affect FMT outcomes in kids?

    Current Mayo Clinic protocols require that children undergoing fecal microbial transplant for recurrent C. difficile infection supply fresh, familial donor stool. A new study is evaluating whether frozen stool from anon[...]

  101. Nov. 12, 2016

    Food sensitivities may affect gut barrier function

    Despite growing evidence implicating dietary factors in dysregulated gut barrier function, much about these interactions isn't clear, especially in the absence of food sensitivity biomarkers and validated assays for int[...]

  102. Nov. 12, 2016

    Researchers identify FAH mutation without elevated succinylacetone

    Three siblings with classic symptoms of tyrosinemia type 1 but without elevated levels of succinylacetone were seen at Mayo Clinic in 2013. Their case led to the discovery of a novel FAH genetic variation.

  103. Nov. 12, 2016

    Still no optimal treatments for pediatric AP

    The incidence of pediatric acute pancreatitis (AP) has increased over the last two decades due to better recognition in children. Most kids recover quickly with supportive care. But those with recurrent AP may experienc[...]

  104. Sept. 17, 2016

    Study demonstrates efficacy of EUS-guided stent placement

    In experienced centers, EUS-guided duct drainage has a relatively high success rate. But the procedure is among the most technically challenging for endoscopists and carries potentially serious risks.

  105. Sept. 13, 2016

    Healthy Living Program offers new approach to functional GI disorders

    Mayo Clinic's Healthy Living Program offers wellness plans for fundamentally healthy people wanting to maximize fitness, lose weight and manage stress. The same approach may help patients with functional bowel disorders[...]

  106. Sept. 13, 2016

    Endoscopic management of post-transplant biliary strictures

    Endoscopic interventions for biliary strictures after liver transplantation have a high success rate and are the preferred approach in patients with duct-to-duct anastomoses.

  107. Sept. 13, 2016

    Linking patients with effective weight management strategies

    A broad spectrum of nutritional, behavioral, pharmacological, endoscopic and surgical therapies is essential for managing obesity, its complications and comorbidities.

  108. July 16, 2016

    Multidisciplinary treatment in rectal cancer

    Despite improvements in preoperative tumor staging and outcomes, evaluation and management of locally advanced rectal cancer presents ongoing challenges for physicians and patients, highlighting the need for multidiscip[...]

  109. July 15, 2016

    Laparoscopic proctectomy not ready for prime time

    Despite positive results in other trials and against expectations, laparoscopic surgery for rectal cancer did not prove equivalent to open resection in the 2015 ACOSOG trial.

  110. July 15, 2016

    Stool DNA has potential for multiple cancer screenings

    Methylated DNA may not only provide an affordable, noninvasive method for pancreatic cancer screening but also represent a first step toward a universal cancer screening test.

  111. July 15, 2016

    Aspirin a potential chemopreventive agent for cholangiocarcinoma

    Building on a long history of aspirin research, Mayo investigators find an association between aspirin use and a significant reduction in the three subtypes of cholangiocarcinoma.

  112. May 13, 2016

    Hemorrhoidal disease: Diagnosis and management

    Rubber band ligation has been shown to be a safe, effective and painless therapy for grade I and grade II hemorrhoids. Although less durable than surgical excision, it is also less costly, has fewer complications and ze[...]

  113. May 13, 2016

    Genetic risk profile predicts early CD surgery

    Clinicians generally have no way of knowing which patients with newly diagnosed Crohn's disease will experience rapid disease progression and early surgery. Three new genetic risk profiles may change that.

  114. May 13, 2016

    Innovations improve achalasia diagnosis, management

    In the last decade, high-resolution manometry, esophageal bolus transit assessment by intraluminal impedance and distensibility assessment with the EndoFlip probe have significantly improved treatment and management of [...]

  115. May 13, 2016

    If it's not celiac disease, what is it?

    The role of gluten and FODMAPs in patients presenting with IBS-symptoms remains unclear. Persuasive studies exist on all sides of the debate.

  116. May 07, 2016

    Studies rebut common theories about pediatric celiac disease

    Children with celiac disease may not have the same fat-soluble vitamin deficiencies observed in adults but may take longer for complete mucosal healing than once thought, according to two recent studies.

  117. April 08, 2016

    Intragastric balloon safe and effective in total weight management program

    The intragastric balloon procedure represents an intermediate option — between lifestyle change and bariatric surgery — for patients with a BMI of 30 to 40 kg/m2.

  118. March 19, 2016

    Proton beam therapy reduces toxicity, increases survival in some GI cancers

    Proton beam therapy can create dose distributions that conform to tumor targets with significant sparing of normal tissue. This may make it a superior modality for some gastrointestinal cancers.

  119. March 18, 2016

    Managing refractory IBD

    A majority of patients with IBD fail to respond to standard medical treatment or lose response over time. Managing these patients requires an understanding of the available medications and appropriate diagnostic tests a[...]

  120. March 18, 2016

    More data needed to guide pancreatic cyst management

    Current guidelines for management of pancreatic cysts provide conflicting recommendations that confuse both physicians and patients. A Mayo Clinic pancreas expert offers this suggestion: "Stop producing guidelines and s[...]

  121. March 18, 2016

    Easing transition and transfer for pediatric patients with IBD

    Medical, physical and psychosocial barriers challenge young patients with IBD as they transition to self-management and the adult health care system. Mayo Clinic is developing programs to help ease the way.

  122. Feb. 26, 2016

    Most patients with HCV cured with new drugs — but at what price?

    Assessment of the extent of liver disease is critical in patients with hepatitis C virus (HCV). Insurers may be reluctant to cover patients with HCV who don't have advanced cirrhosis or fibrosis. Mayo offers noninvasive[...]

  123. Jan. 21, 2016

    Liver transplantation and obesity: Weighing the risks

    Although early studies linking obesity with worse survival among liver transplant recipients are flawed, obesity in general and post-transplant weight gain in particular increase the risk of perioperative and postoperat[...]

  124. Jan. 19, 2016

    Rethinking comparative effectiveness research

    IBD effectiveness trials are needed to foster evidence-based changes in clinical practice, but remain challenging to fund and recruit. An IBD specialist says investigators must become more creative in their approach to [...]

  125. Jan. 16, 2016

    FISH probes improve detection of cholangiocarcinoma

    Fluorescence in situ hybridization (FISH) and tumor genotyping may improve evaluation and management of challenging cholangiocarcinomas.

  126. Sept. 05, 2015

    Current and future treatments for irritable bowel syndrome associated with diarrhea

    Better agents needed for IBS-D - Pharmacological treatments for diarrhea-predominant irritable bowel syndrome (IBS-D) are limited and often fail to relieve pain or the full spectrum of associated symptoms. An expert dis[...]

  127. May 30, 2015

    Pulmonary vascular complications of chronic liver disease

    Mayo pulmonologists with expertise in the management of portopulmonary hypertension (POPH) and hepatopulmonary syndrome (HPS) help care for patients with chronic liver disease secondary to cirrhosis.

  128. March 28, 2015

    FMT demonstrates consistently high success rates for recurrent CDI

    Fecal microbiota transplantation (FMT), although not yet a first line therapy, is increasingly recognized as a safe and effective intervention for patients with recurrent Clostridium difficile infection (CDI). FMT resto[...]

  129. March 28, 2015

    Alpha-1-antitrypsin deficiency: A liver-lung connection

    Alpha-1-antitrypsin (AAt) deficiency is an inherited disorder that results in liver disease, lung disease or both. Patients with liver dysfunction and early-stage chronic obstructive lung disease or asthma that does not[...]

  130. Dec. 03, 2014

    Cologuard primed to change landscape of CRC screening

    Recently approved by the FDA and simultaneously covered by Medicare, Cologuard is a noninvasive stool DNA screening test for colorectal cancer with demonstrated 92 percent sensitivity in detecting cancer stages I-IV and[...]

  131. Oct. 02, 2014

    PCLE helps visualize changes in gut permeability

    Increased intestinal permeability has a pathogenic role in celiac disease, IBS and non-celiac gluten sensitivity. Now, two clinical trials are using probe-based confocal laser endomicroscopy to further investigate the r[...]

  132. June 04, 2014

    Gluten may not be culprit in nonresponsive celiac disease

    Celiac disease patients fail to respond to a gluten-free diet for many reasons, including gluten contamination, misdiagnosis and other gastrointestinal disorders. When these possibilities have been excluded, refractory [...]

  133. April 02, 2014

    Tests aid diagnosis of an under-recognized disorder

    Tests aid diagnosis of an under-recognized disorder — Bile acid malabsorption (BAM) is an underdiagnosed cause of chronic diarrhea, due mainly to limited availability of the gold standard SeHCAT retention test. Th[...]

  134. Dec. 20, 2013

    Plastic vs. metal stents for malignant biliary obstruction

    Biliary stent choice depends on cost, patient prognosis - Both plastic and metal stents used for symptom relief in patients with malignant biliary obstruction have limitations. Cost-effectiveness, safety and patient pro[...]